purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Drugs
1.2 Key Market Segments
1.2.1 Nucleic Acid Drugs Segment by Type
1.2.2 Nucleic Acid Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Nucleic Acid Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Drugs Market Competitive Landscape
3.1 Global Nucleic Acid Drugs Sales by Manufacturers (2019-2025)
3.2 Global Nucleic Acid Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Nucleic Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Nucleic Acid Drugs Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Drugs Market Competitive Situation and Trends
3.6.1 Nucleic Acid Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Drugs Industry Chain Analysis
4.1 Nucleic Acid Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Drugs Sales Market Share by Type (2019-2025)
6.3 Global Nucleic Acid Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Nucleic Acid Drugs Price by Type (2019-2025)
7 Nucleic Acid Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Drugs Market Sales by Application (2019-2025)
7.3 Global Nucleic Acid Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Nucleic Acid Drugs Sales Growth Rate by Application (2019-2025)
8 Nucleic Acid Drugs Market Consumption by Region
8.1 Global Nucleic Acid Drugs Sales by Region
8.1.1 Global Nucleic Acid Drugs Sales by Region
8.1.2 Global Nucleic Acid Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Nucleic Acid Drugs Market Production by Region
9.1 Global Production of Nucleic Acid Drugs by Region (2019-2025)
9.2 Global Nucleic Acid Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Nucleic Acid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Nucleic Acid Drugs Production
9.4.1 North America Nucleic Acid Drugs Production Growth Rate (2019-2025)
9.4.2 North America Nucleic Acid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Nucleic Acid Drugs Production
9.5.1 Europe Nucleic Acid Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Nucleic Acid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Nucleic Acid Drugs Production (2019-2025)
9.6.1 Japan Nucleic Acid Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Nucleic Acid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Nucleic Acid Drugs Production (2019-2025)
9.7.1 China Nucleic Acid Drugs Production Growth Rate (2019-2025)
9.7.2 China Nucleic Acid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Nucleic Acid Drugs Basic Information
10.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Overview
10.1.3 Sarepta Therapeutics Nucleic Acid Drugs Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics Nucleic Acid Drugs SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Nucleic Acid Drugs Basic Information
10.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Overview
10.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals Nucleic Acid Drugs SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Nucleic Acid Drugs Basic Information
10.3.2 Alnylam Nucleic Acid Drugs Product Overview
10.3.3 Alnylam Nucleic Acid Drugs Product Market Performance
10.3.4 Alnylam Nucleic Acid Drugs SWOT Analysis
10.3.5 Alnylam Business Overview
10.3.6 Alnylam Recent Developments
10.4 Mina Therapeutics
10.4.1 Mina Therapeutics Nucleic Acid Drugs Basic Information
10.4.2 Mina Therapeutics Nucleic Acid Drugs Product Overview
10.4.3 Mina Therapeutics Nucleic Acid Drugs Product Market Performance
10.4.4 Mina Therapeutics Business Overview
10.4.5 Mina Therapeutics Recent Developments
10.5 BioNTech
10.5.1 BioNTech Nucleic Acid Drugs Basic Information
10.5.2 BioNTech Nucleic Acid Drugs Product Overview
10.5.3 BioNTech Nucleic Acid Drugs Product Market Performance
10.5.4 BioNTech Business Overview
10.5.5 BioNTech Recent Developments
10.6 NeXstar Pharmaceuticals
10.6.1 NeXstar Pharmaceuticals Nucleic Acid Drugs Basic Information
10.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Overview
10.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Market Performance
10.6.4 NeXstar Pharmaceuticals Business Overview
10.6.5 NeXstar Pharmaceuticals Recent Developments
10.7 Nippon Shinyaku
10.7.1 Nippon Shinyaku Nucleic Acid Drugs Basic Information
10.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Overview
10.7.3 Nippon Shinyaku Nucleic Acid Drugs Product Market Performance
10.7.4 Nippon Shinyaku Business Overview
10.7.5 Nippon Shinyaku Recent Developments
10.8 Moderna Therapeutics
10.8.1 Moderna Therapeutics Nucleic Acid Drugs Basic Information
10.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Overview
10.8.3 Moderna Therapeutics Nucleic Acid Drugs Product Market Performance
10.8.4 Moderna Therapeutics Business Overview
10.8.5 Moderna Therapeutics Recent Developments
10.9 CureVac
10.9.1 CureVac Nucleic Acid Drugs Basic Information
10.9.2 CureVac Nucleic Acid Drugs Product Overview
10.9.3 CureVac Nucleic Acid Drugs Product Market Performance
10.9.4 CureVac Business Overview
10.9.5 CureVac Recent Developments
10.10 Regulus Therapeutics
10.10.1 Regulus Therapeutics Nucleic Acid Drugs Basic Information
10.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Overview
10.10.3 Regulus Therapeutics Nucleic Acid Drugs Product Market Performance
10.10.4 Regulus Therapeutics Business Overview
10.10.5 Regulus Therapeutics Recent Developments
10.11 Miragen Therapeutics
10.11.1 Miragen Therapeutics Nucleic Acid Drugs Basic Information
10.11.2 Miragen Therapeutics Nucleic Acid Drugs Product Overview
10.11.3 Miragen Therapeutics Nucleic Acid Drugs Product Market Performance
10.11.4 Miragen Therapeutics Business Overview
10.11.5 Miragen Therapeutics Recent Developments
11 Nucleic Acid Drugs Market Forecast by Region
11.1 Global Nucleic Acid Drugs Market Size Forecast
11.2 Global Nucleic Acid Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid Drugs Market Size Forecast by Region
11.2.4 South America Nucleic Acid Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Nucleic Acid Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Nucleic Acid Drugs by Type (2025-2032)
12.1.2 Global Nucleic Acid Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Nucleic Acid Drugs by Type (2025-2032)
12.2 Global Nucleic Acid Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Nucleic Acid Drugs Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings